University of Cincinnati
Cincinnati, Ohio, 45267, United States
NCT Number: NCT02858349
Subjects with stroke will have behavioral testing and brain imaging before and after a 4-week control period and a 4-week exercise intervention.
Looking for future studies?
Notify Me30 year–90 year
All sexes
Interventional
Not applicable
Cincinnati, Ohio, 45267, United States
Subjects with stroke will have behavioral testing and brain imaging before and after a 4-week control period and a 4-week exercise intervention using high-intensity interval training.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
No intervention
High-intensity walking exercise using bursts of concentrated effort alternated with recovery periods
Time frame: Change from 4-weeks to 8-weeks
10-meter walk test
Time frame: baseline, 4 weeks, 8 weeks
Paretic step ratio
Time frame: baseline, 4 weeks, 8 weeks
oxygen consumption rate during comfortable speed gait
Time frame: baseline, 4 weeks, 8 weeks
oxygen consumption rate during exercise testing
Time frame: baseline, 4 weeks, 8 weeks
Time frame: baseline, 4 weeks, 8 weeks
Time frame: baseline, 4 weeks, 8 weeks
Time frame: baseline, 4 weeks, 8 weeks
Time frame: baseline, 4 weeks, 8 weeks
Time frame: baseline, 4 weeks, 8 weeks
6-minute walk test
Time frame: baseline, 4 weeks, 8 weeks
activity monitor
Time frame: baseline, 4 weeks, 8 weeks
10-meter walk test
University of Cincinnati
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03969927
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Kansas City, Kansas, United States
View Trial DetailsNCT04685408
Brain Diseases, Cardiovascular Diseases
Kampala, Uganda
View Trial DetailsNCT05016531
Brain Diseases, Cardiovascular Diseases
Durham, North Carolina, United States
View Trial DetailsNCT07751224
Brain Diseases, Cardiovascular Diseases
Ho Chi Minh City, Vietnam
View Trial Details